Skip NavigationSkip to Content

Antineoplastic agents 442. Synthesis and biological activities of dioxostatin

  1. Author:
    Pettit, G. R.
    Lippert, J. W.
    Boyd, M. R.
    Verdier-Pinard, P.
    Hamel, E.
  2. Author Address

    Arizona State Univ, Canc Res Inst, POB 872404, Tempe, AZ 85287 USA. Arizona State Univ, Canc Res Inst, Tempe, AZ 85287 USA. Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA. NCI, Frederick Canc Res & Dev Ctr, Lab Drug Discovery Res, Frederick, MD 21702 USA. NCI, Frederick Canc Res & Dev Ctr, Dev & Screening Technol Branch, DTP DCTD, Frederick, MD 21702 USA. Pettit GR Arizona State Univ, Canc Res Inst, POB 872404, Tempe, AZ 85287 USA.
    1. Year: 2000
  1. Journal: Anti-Cancer Drug Design
    1. 15
    2. 5
    3. Pages: 361-371
  2. Type of Article: Article
  1. Abstract:

    A high-yield regioselective synthesis of (E)-combretastatin A-1 2b was completed using methoxymethyl (MOM) protection and a Wadsworth-Emmons reaction as key steps. In turn, (E)-stilbene 11 was converted by convenient syntheses to both (S,S)- and (R,R)-1,3-dioxolanes 5a and 6a. A Sharpless asymmetric dihydroxylation reaction was employed for preparation of intermediates (S,S)-12 and (R,R)-13. The (4S,5S)-4-(2 ' ,3 ' dihydroxy-4 ' -methoxyphenyl)-5-(3 " ,4 " ,5 " - trimethoxyphenyl)-1, 3-dioxolane 5a was found to be a highly potent inhibitor of microtubule assembly (IC50 = 0.59 muM) and was designated dioxostatin. Conversion to sodium phosphate 17 (P388 lymphocytic leukemia cell line: ED50 = 0.2 mug/ml) provided a very useful water-soluble prodrug.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel